Incidence of neuroblastoma after a screening program

Journal of Clinical Oncology

Volumn 25, Issue 31, 2007, Pages 4929-4932

  Barrette, Stéphane ^a   Bernstein, Mark L ^a   Robison, Leslie L ^a   Samson, Yvan ^a   Brossard, Josée ^a   Weitzman, Sheila ^a   Woods, William G ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANADA; CANCER SCREENING; CONTROLLED STUDY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; NEUROBLASTOMA; PRIORITY JOURNAL; URINALYSIS;

CHILD, PRESCHOOL; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MASS SCREENING; MINNESOTA; NEUROBLASTOMA; ONTARIO; QUEBEC;

EID: 36849055608     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.12.1905     Document Type: Article

References (15)

1. Ries LAG, Eisner MP, Kosary CL, et al: SEER Cancer Statistics Review, 1975-2002. Bethesda, MD, National Cancer Institute, 2002
2. Shimada H, Umehara S, Monobe Y, et al: International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: A report from the Children's Cancer Group. Cancer 92:2451-2461, 2001
3. Ikeda H, Iehara T, Tsuchida Y, et al: Experience with International Neuroblastoma Staging System and Pathology Classification. Br J Cancer 86:1110-1116, 2002
4. Tuchman M, Lemieux B, Auray-Blais C, et al: Screening for neuroblastoma at 3 weeks of age: Methods and preliminary results from the Quebec Neuroblastoma Screening Project. Pediatrics 86:765-773, 1990
5. Berthold F, Baillot A, Hero B, et al: Which cases are found and missed by neuroblastoma screening at 1 year? Results from the 1992 to 1995 study in three Federal States of Germany. J Clin Oncol 17:1200-1207, 1999
6. Honjo S, Doran HE, Stiller CA, et al: Neuroblastoma trends in Osaka, Japan, and Great Britain 1970-1994, in relation to screening. Int J Cancer 103:538-543, 2003
7. Carlsen NL: Neuroblastoma: Epidemiology and pattern of regression: Problems in interpreting results of mass screening. Am J Pediatr Hematol Oncol 14:103-110, 1992
8. Woods WG, Tuchman M, Robison LL, et al: A population-based study of the usefulness of screening for neuroblastoma. Lancet 348:1682-1687, 1996
9. Woods WG, Gao RN, Shuster JJ, et al: Screening of infants and mortality due to neuroblastoma. N Engl J Med 346:1041-1046, 2002
10. Campion P, Woods WG, Lemieux B: Compliance in a screening program for neuroblastoma. Prev Med 27:590-596, 1998
11. Bernstein ML, Leclerc JM, Bunin G, et al: A population-based study of neuroblastoma incidence, survival and mortality in North America. J Clin Oncol 10:323-329, 1992
12. Barrette S, Bernstein ML, Leclerc JM, et al: Treatment complications in children diagnosed with neuroblastoma during a screening program. J Clin Oncol 24:1542-1545, 2006
13. Etzioni R, Penson DF, Legler JM, et al: Overdiagnosis due to prostate-specific antigen screening: Lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst 94:981-990, 2002
14. Gotzsche PC, Nielsen M: Screening for breast cancer with mammography. Oxford, United Kingdom, Cochrane Library, CD001877, 4, 2006
15. Prorok PC, Andriole GL, Bresalier RS et al: Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Control Clin Trials 21:273S-309S, 2000